Saul Schaefer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Saul Schaefer has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Ravichandran Ramasamy
Diabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, USA
4 shared publications - Elena N. Dedkova
Department of Molecular Biosciences, University of California, Davis, CA 95616, USA
3 shared publications Ahmadreza Ghasemiesfe
Radiology, Division of Cardiothoracic Imaging, UC Davis Health, Sacramento, USA
2 shared publications- Bora Inceoglu
Department of Entomology, University of California, Davis, CA 95616, USA
2 shared publications - Donald M. Bers
Department of Pharmacology, University of California, Davis (J.T., D.M.B.).
2 shared publications Gennady Cherednichenko
Cardiology Section, VA Northern California Health Care System
2 shared publications
Latest Publications
- Open Access
- 4 April 2026
- Published by Wiley in The Journal of Physiology
- Vol. 604 (16) , 6943-6958
Ro5‐4864, a ligand of the mitochondrial translocator protein, protects against heart failure in mice via regulation of the p62‐Keap1‐Nrf2 axis
The 18‐kDa mitochondrial translocator protein (TSPO) has been shown to modulate mitochondrial function and the cardiac response to pressure overload. We have previously shown that conditional knockout of TSPO limited the development of heart failure in the murine model of transverse aortic constriction (TAC). In this study, we hypothesized that similar protection could be achieved by a ligand of TSPO, Ro5‐4864 (Ro5), in an in‐vivo model of pressure‐overload induced heart failure. To test this hypothesis, C57/BL6J mice had TAC or sham surgery, with daily 0.1 mg/kg Ro5 or saline intra‐peritoneal injection for 8 weeks, with echocardiographic measurement of left ventricular (LV) size and function. Cardiac tissue protein expression was then analyzed by LC/MS. Markers of inflammation were quantified via western blot. Isolated murine cardiomyocytes were co‐treated with 25 µM H 2 O 2 and 2.5 µg Ro5 to investigate oxidative stress. The results of these experiments showed that Ro5‐4864 significantly prevented the TAC‐induced decline in LV function, as well as the associated increases in natriuretic peptide A and collagen alpha‐1 (XII) expression observed in saline‐treated animals. Ro5‐4864 also reduced oxidative stress and activated the Nrf2 pathway, likely due to decreased p62 accumulation secondary to enhanced mitophagy and restoration of autophagic flux. These in vivo findings were supported by complementary in vitro experiments in cardiomyocytes, where Ro5 attenuated oxidative stress induced by exogenous H 2 O 2 . In conclusion, these results indicate that Ro5‐4864 mitigates the development of pressure overload induced heart failure in mice, suggesting that pharmacologic modulation of the TSPO represents a promising therapeutic strategy for the prevention or treatment of heart failure. image Key points: This study employed Ro5‐4864, a ligand of the mitochondrial translocator protein (TSPO), to test the hypothesis that pharmacologic inhibition of TSPO could limit the development of heart failure in a murine model of transverse aortic constriction (TAC). Ro5‐4864 preserved left ventricular function after TAC and limited the biochemical markers of heart failure and fibrosis. Proteomic analysis showed a significant effect of Ro5 on markers of immune activation, oxidative stress and inflammation. Ro5‐4864 increased the expression of Nrf2, a transcription factor that induces cytoprotective proteins such as NQO1 and SOD2, coupled with regulators of Nrf2 such as p62 and Keap1. These data establish a foundation for further development of anti‐inflammatory interventions in heart failure.
- 4 April 2026
- Published by Wiley in The Journal of Physiology
- Vol. 604 (16) , 6943-6958
Open AccessRo5‐4864, a ligand of the mitochondrial translocator protein, protects against heart failure in mice via regulation of the p62‐Keap1‐Nrf2 axis
The 18‐kDa mitochondrial translocator protein (TSPO) has been shown to modulate mitochondrial function and the cardiac response to pressure overload. We have previously shown that conditional knockout of TSPO limited the development of heart failure in the murine model of transverse aortic constriction (TAC). In this study, we hypothesized that similar protection could be achieved by a ligand of TSPO, Ro5‐4864 (Ro5), in an in‐vivo model of pressure‐overload induced heart failure. To test this hypothesis, C57/BL6J mice had TAC or sham surgery, with daily 0.1 mg/kg Ro5 or saline intra‐peritoneal injection for 8 weeks, with echocardiographic measurement of left ventricular (LV) size and function. Cardiac tissue protein expression was then analyzed by LC/MS. Markers of inflammation were quantified via western blot. Isolated murine cardiomyocytes were co‐treated with 25 µM H 2 O 2 and 2.5 µg Ro5 to investigate oxidative stress. The results of these experiments showed that Ro5‐4864 significantly prevented the TAC‐induced decline in LV function, as well as the associated increases in natriuretic peptide A and collagen alpha‐1 (XII) expression observed in saline‐treated animals. Ro5‐4864 also reduced oxidative stress and activated the Nrf2 pathway, likely due to decreased p62 accumulation secondary to enhanced mitophagy and restoration of autophagic flux. These in vivo findings were supported by complementary in vitro experiments in cardiomyocytes, where Ro5 attenuated oxidative stress induced by exogenous H 2 O 2 . In conclusion, these results indicate that Ro5‐4864 mitigates the development of pressure overload induced heart failure in mice, suggesting that pharmacologic modulation of the TSPO represents a promising therapeutic strategy for the prevention or treatment of heart failure. image Key points: This study employed Ro5‐4864, a ligand of the mitochondrial translocator protein (TSPO), to test the hypothesis that pharmacologic inhibition of TSPO could limit the development of heart failure in a murine model of transverse aortic constriction (TAC). Ro5‐4864 preserved left ventricular function after TAC and limited the biochemical markers of heart failure and fibrosis. Proteomic analysis showed a significant effect of Ro5 on markers of immune activation, oxidative stress and inflammation. Ro5‐4864 increased the expression of Nrf2, a transcription factor that induces cytoprotective proteins such as NQO1 and SOD2, coupled with regulators of Nrf2 such as p62 and Keap1. These data establish a foundation for further development of anti‐inflammatory interventions in heart failure.
- Open Access
- 17 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10)
Can Fractional Flow Reserve-Computed Tomography (FFR-CT) Overestimate the Severity of Coronary Stenoses in the Presence of High Calcium Burden?
Non-invasive diagnostic methods such as coronary artery calcium (CAC) scoring, computed tomography angiography (CTA), and fractional flow reserve-computed tomography (FFR-CT) are useful to predict the presence of coronary artery stenosis, but may provide false positive results as well. This case describes a man in his mid-60s with significant cardiac history who presented to the emergency department with chest pain. Extensive workup included CTA, which demonstrated severe coronary artery calcification and abnormal FFR-CT suggestive of severe three-vessel disease. Urgent invasive coronary angiography was performed due to his high likelihood of flow-limiting stenosis; however, it revealed only mild-to-moderate non-obstructive (<50%) stenoses. This report highlights the potential of CAC, CTA, and FFR-CT to overestimate the severity of coronary artery disease.
- 17 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10)
Open AccessCan Fractional Flow Reserve-Computed Tomography (FFR-CT) Overestimate the Severity of Coronary Stenoses in the Presence of High Calcium Burden?
Non-invasive diagnostic methods such as coronary artery calcium (CAC) scoring, computed tomography angiography (CTA), and fractional flow reserve-computed tomography (FFR-CT) are useful to predict the presence of coronary artery stenosis, but may provide false positive results as well. This case describes a man in his mid-60s with significant cardiac history who presented to the emergency department with chest pain. Extensive workup included CTA, which demonstrated severe coronary artery calcification and abnormal FFR-CT suggestive of severe three-vessel disease. Urgent invasive coronary angiography was performed due to his high likelihood of flow-limiting stenosis; however, it revealed only mild-to-moderate non-obstructive (<50%) stenoses. This report highlights the potential of CAC, CTA, and FFR-CT to overestimate the severity of coronary artery disease.
- Open Access
- 26 February 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (8) , 103241
Advanced Imaging in the Diagnosis of Cardiac Sarcoid and LV Noncompaction
- 26 February 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (8) , 103241
Open AccessAdvanced Imaging in the Diagnosis of Cardiac Sarcoid and LV Noncompaction
- 1 January 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (1) , e012530
Is It Primetime for Finerenone in Heart Failure?
- 1 January 2025
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 18 (1) , e012530
Is It Primetime for Finerenone in Heart Failure?
- Open Access
- 14 August 2024
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 19, 100723
Will DANCAVAS be the most important screening trial in the last 50 years?
- 14 August 2024
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 19, 100723
Open AccessWill DANCAVAS be the most important screening trial in the last 50 years?
- Open Access
- 5 October 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (19) , e020729
Ketone Ester D‐β‐Hydroxybutyrate‐(R)‐1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice
Background: Heart failure is responsible for approximately 65% of deaths in patients with type 2 diabetes mellitus. However, existing therapeutics for type 2 diabetes mellitus have limited success on the prevention of diabetic cardiomyopathy. The aim of this study was to determine whether moderate elevation in D‐β‐hydroxybutyrate improves cardiac function in animals with type 2 diabetes mellitus. Methods and Results: Type 2 diabetic (db/db) and their corresponding wild‐type mice were fed a control diet or a diet where carbohydrates were equicalorically replaced by D‐β‐hydroxybutyrate‐(R)‐1,3 butanediol monoester (ketone ester [KE]). After 4 weeks, echocardiography demonstrated that a KE diet improved systolic and diastolic function in db/db mice. A KE diet increased expression of mitochondrial succinyl‐CoA:3‐oxoacid‐CoA transferase and restored decreased expression of mitochondrial β‐hydroxybutyrate dehydrogenase, key enzymes in cardiac ketone metabolism. A KE diet significantly enhanced both basal and ADP‐mediated oxygen consumption in cardiac mitochondria from both wild‐type and db/db animals; however, it did not result in the increased mitochondrial respiratory control ratio. Additionally, db/db mice on a KE diet had increased resistance to oxidative and redox stress, with evidence of restoration of decreased expression of thioredoxin and glutathione peroxidase 4 and less permeability transition pore activity in mitochondria. Mitochondrial biogenesis, quality control, and elimination of dysfunctional mitochondria via mitophagy were significantly increased in cardiomyocytes from db/db mice on a KE diet. The increase in mitophagy was correlated with restoration of mitofusin 2 expression, which contributed to improved coupling between cytosolic E3 ubiquitin ligase translocation into mitochondria and microtubule‐associated protein 1 light chain 3–mediated autophagosome formation. Conclusions: Moderate elevation in circulating D‐β‐hydroxybutyrate levels via KE supplementation enhances mitochondrial biogenesis, quality control, and oxygen consumption and increases resistance to oxidative/redox stress and mPTP opening, thus resulting in improvement of cardiac function in animals with type 2 diabetes mellitus.
- 5 October 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (19) , e020729
Open AccessKetone Ester D‐β‐Hydroxybutyrate‐(R)‐1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice
Background: Heart failure is responsible for approximately 65% of deaths in patients with type 2 diabetes mellitus. However, existing therapeutics for type 2 diabetes mellitus have limited success on the prevention of diabetic cardiomyopathy. The aim of this study was to determine whether moderate elevation in D‐β‐hydroxybutyrate improves cardiac function in animals with type 2 diabetes mellitus. Methods and Results: Type 2 diabetic (db/db) and their corresponding wild‐type mice were fed a control diet or a diet where carbohydrates were equicalorically replaced by D‐β‐hydroxybutyrate‐(R)‐1,3 butanediol monoester (ketone ester [KE]). After 4 weeks, echocardiography demonstrated that a KE diet improved systolic and diastolic function in db/db mice. A KE diet increased expression of mitochondrial succinyl‐CoA:3‐oxoacid‐CoA transferase and restored decreased expression of mitochondrial β‐hydroxybutyrate dehydrogenase, key enzymes in cardiac ketone metabolism. A KE diet significantly enhanced both basal and ADP‐mediated oxygen consumption in cardiac mitochondria from both wild‐type and db/db animals; however, it did not result in the increased mitochondrial respiratory control ratio. Additionally, db/db mice on a KE diet had increased resistance to oxidative and redox stress, with evidence of restoration of decreased expression of thioredoxin and glutathione peroxidase 4 and less permeability transition pore activity in mitochondria. Mitochondrial biogenesis, quality control, and elimination of dysfunctional mitochondria via mitophagy were significantly increased in cardiomyocytes from db/db mice on a KE diet. The increase in mitophagy was correlated with restoration of mitofusin 2 expression, which contributed to improved coupling between cytosolic E3 ubiquitin ligase translocation into mitochondria and microtubule‐associated protein 1 light chain 3–mediated autophagosome formation. Conclusions: Moderate elevation in circulating D‐β‐hydroxybutyrate levels via KE supplementation enhances mitochondrial biogenesis, quality control, and oxygen consumption and increases resistance to oxidative/redox stress and mPTP opening, thus resulting in improvement of cardiac function in animals with type 2 diabetes mellitus.
- Open Access
- 2 November 2020
- Published by Springer Nature in Cureus
- Vol. 12 (11)
“Cool Knees” as a Measure of Systemic Vascular Resistance in Cardiac Patients
Introduction: Clinical assessment of cardiac output (CO) and systemic vascular resistance (SVR) in cardiac patients is often inaccurate. Since the genicular arteries form a watershed zone accessible to physical examination, we hypothesized that “cool knees” would reflect abnormalities in central hemodynamics. Methods: Nineteen patients with cardiac diagnoses, but without distributive shock, had a measurement of skin temperature over the thigh, knee, and foot in parallel with central hemodynamics derived from invasive monitoring. Results: The temperature gradient from thigh to knee (DTK) reflected increased SVR, and was significantly correlated with SVR, cardiac index (CI), and CO. Cool feet (DTF) were significantly correlated only with systemic hypotension, but not central hemodynamics. Conclusion: Cool knees reflect increased SVR in cardiac patients and may be an important physical exam finding in their assessment and management.
- 2 November 2020
- Published by Springer Nature in Cureus
- Vol. 12 (11)
Open Access“Cool Knees” as a Measure of Systemic Vascular Resistance in Cardiac Patients
Introduction: Clinical assessment of cardiac output (CO) and systemic vascular resistance (SVR) in cardiac patients is often inaccurate. Since the genicular arteries form a watershed zone accessible to physical examination, we hypothesized that “cool knees” would reflect abnormalities in central hemodynamics. Methods: Nineteen patients with cardiac diagnoses, but without distributive shock, had a measurement of skin temperature over the thigh, knee, and foot in parallel with central hemodynamics derived from invasive monitoring. Results: The temperature gradient from thigh to knee (DTK) reflected increased SVR, and was significantly correlated with SVR, cardiac index (CI), and CO. Cool feet (DTF) were significantly correlated only with systemic hypotension, but not central hemodynamics. Conclusion: Cool knees reflect increased SVR in cardiac patients and may be an important physical exam finding in their assessment and management.
- Open Access
- 1 November 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-17
Cardiac-specific Conditional Knockout of the 18-kDa Mitochondrial Translocator Protein Protects from Pressure Overload Induced Heart Failure
Heart failure (HF) is characterized by abnormal mitochondrial calcium (Ca2+) handling, energy failure and impaired mitophagy resulting in contractile dysfunction and myocyte death. We have previously shown that the 18-kDa mitochondrial translocator protein of the outer mitochondrial membrane (TSPO) can modulate mitochondrial Ca2+ uptake. Experiments were designed to test the role of the TSPO in a murine pressure-overload model of HF induced by transverse aortic constriction (TAC). Conditional, cardiac-specific TSPO knockout (KO) mice were generated using the Cre-loxP system. TSPO-KO and wild-type (WT) mice underwent TAC for 8 weeks. TAC-induced HF significantly increased TSPO expression in WT mice, associated with a marked reduction in systolic function, mitochondrial Ca2+ uptake, complex I activity and energetics. In contrast, TSPO-KO mice undergoing TAC had preserved ejection fraction, and exhibited fewer clinical signs of HF and fibrosis. Mitochondrial Ca2+ uptake and energetics were restored in TSPO KO mice, associated with decreased ROS, improved complex I activity and preserved mitophagy. Thus, HF increases TSPO expression, while preventing this increase limits the progression of HF, preserves ATP production and decreases oxidative stress, thereby preventing metabolic failure. These findings suggest that pharmacological interventions directed at TSPO may provide novel therapeutics to prevent or treat HF.
- 1 November 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-17
Open AccessCardiac-specific Conditional Knockout of the 18-kDa Mitochondrial Translocator Protein Protects from Pressure Overload Induced Heart Failure
Heart failure (HF) is characterized by abnormal mitochondrial calcium (Ca2+) handling, energy failure and impaired mitophagy resulting in contractile dysfunction and myocyte death. We have previously shown that the 18-kDa mitochondrial translocator protein of the outer mitochondrial membrane (TSPO) can modulate mitochondrial Ca2+ uptake. Experiments were designed to test the role of the TSPO in a murine pressure-overload model of HF induced by transverse aortic constriction (TAC). Conditional, cardiac-specific TSPO knockout (KO) mice were generated using the Cre-loxP system. TSPO-KO and wild-type (WT) mice underwent TAC for 8 weeks. TAC-induced HF significantly increased TSPO expression in WT mice, associated with a marked reduction in systolic function, mitochondrial Ca2+ uptake, complex I activity and energetics. In contrast, TSPO-KO mice undergoing TAC had preserved ejection fraction, and exhibited fewer clinical signs of HF and fibrosis. Mitochondrial Ca2+ uptake and energetics were restored in TSPO KO mice, associated with decreased ROS, improved complex I activity and preserved mitophagy. Thus, HF increases TSPO expression, while preventing this increase limits the progression of HF, preserves ATP production and decreases oxidative stress, thereby preventing metabolic failure. These findings suggest that pharmacological interventions directed at TSPO may provide novel therapeutics to prevent or treat HF.
- Open Access
- 19 October 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-7
Age-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Does a Normal Age-Adjusted D-Dimer Rule Out PE?
Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decision rules (CDR), and D-dimer testing. There is still controversy regarding the role of D-dimer testing in low or intermediate risk patients. The objective of the study was to define the role of clinical decision rules and D-dimer testing in patients suspected of having a PE. Records of 894 patients referred for computed tomography pulmonary angiography (CTPA) at a University medical center were analyzed. The clinical decision rules overall had an ROC of approximately 0.70, while signs of DVT had the highest ROC (0.80). A low probability CDR coupled with a negative age-adjusted D-dimer largely excluded PE. The negative predictive value (NPV) of an intermediate CDR was 86–89%, while the addition of a negative D-dimer resulted in NPVs of 94%. Thus, in patients suspected of having a PE, a low or intermediate CDR does not exclude PE; however, in patients with an intermediate CDR, a normal age-adjusted D-dimer increases the NPV.
- 19 October 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-7
Open AccessAge-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Does a Normal Age-Adjusted D-Dimer Rule Out PE?
Risk assessment for pulmonary embolism (PE) currently relies on physician judgment, clinical decision rules (CDR), and D-dimer testing. There is still controversy regarding the role of D-dimer testing in low or intermediate risk patients. The objective of the study was to define the role of clinical decision rules and D-dimer testing in patients suspected of having a PE. Records of 894 patients referred for computed tomography pulmonary angiography (CTPA) at a University medical center were analyzed. The clinical decision rules overall had an ROC of approximately 0.70, while signs of DVT had the highest ROC (0.80). A low probability CDR coupled with a negative age-adjusted D-dimer largely excluded PE. The negative predictive value (NPV) of an intermediate CDR was 86–89%, while the addition of a negative D-dimer resulted in NPVs of 94%. Thus, in patients suspected of having a PE, a low or intermediate CDR does not exclude PE; however, in patients with an intermediate CDR, a normal age-adjusted D-dimer increases the NPV.
- Open Access
- 10 March 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , srep08906
Nicotinic Acid is a Common Regulator of Heat-Sensing TRPV1-4 Ion Channels
Nicotinic acid (NA, a.k.a. vitamin B3 or niacin) can reduce blood cholesterol and low-density lipoproteins whereas increase high-density lipoproteins. However, when NA is used to treat dyslipidemias, it causes a strong side effect of cutaneous vasodilation, commonly called flushing. A recent study showed that NA may cause flushing by lowering activation threshold temperature of the heat-sensitive capsaicin receptor TRPV1 ion channel, leading to its activation at body temperature. The finding calls into question whether NA might also interact with the homologous heat-sensitive TRPV2–4 channels, particularly given that TRPV3 and TRPV4 are abundantly expressed in keratinocytes of the skin where much of the flushing response occurs. We found that NA indeed potentiated TRPV3 while inhibited TRPV2 and TRPV4. Consistent with these gating effects, NA lowered the heat-activation threshold of TRPV3 but elevated that of TRPV4. We further found that activity of TRPV1 was substantially prolonged by extracellular NA, which may further enhance the direct activation effect. Consistent with the broad gating effect on TRPV1–4 channels, evidence from the present study hints that NA may share the same activation pathway as 2-aminoethoxydiphenyl borate (2-APB), a common agonist for these TRPV channels. These findings shed new light on the molecular mechanism underlying NA regulation of TRPV channels.
- 10 March 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , srep08906
Open AccessNicotinic Acid is a Common Regulator of Heat-Sensing TRPV1-4 Ion Channels
Nicotinic acid (NA, a.k.a. vitamin B3 or niacin) can reduce blood cholesterol and low-density lipoproteins whereas increase high-density lipoproteins. However, when NA is used to treat dyslipidemias, it causes a strong side effect of cutaneous vasodilation, commonly called flushing. A recent study showed that NA may cause flushing by lowering activation threshold temperature of the heat-sensitive capsaicin receptor TRPV1 ion channel, leading to its activation at body temperature. The finding calls into question whether NA might also interact with the homologous heat-sensitive TRPV2–4 channels, particularly given that TRPV3 and TRPV4 are abundantly expressed in keratinocytes of the skin where much of the flushing response occurs. We found that NA indeed potentiated TRPV3 while inhibited TRPV2 and TRPV4. Consistent with these gating effects, NA lowered the heat-activation threshold of TRPV3 but elevated that of TRPV4. We further found that activity of TRPV1 was substantially prolonged by extracellular NA, which may further enhance the direct activation effect. Consistent with the broad gating effect on TRPV1–4 channels, evidence from the present study hints that NA may share the same activation pathway as 2-aminoethoxydiphenyl borate (2-APB), a common agonist for these TRPV channels. These findings shed new light on the molecular mechanism underlying NA regulation of TRPV channels.